Relay Therapeutics's total assets for Q3 2024 were $930.12M, an increase of 20.40% from the previous quarter. RLAY total liabilities were $91.25M for the fiscal quarter, a 0.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.